These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 2256160)
1. Prolongation of adult skin allograft survival by cotransplantation of neonatal skin in antilymphocyte serum and donor bone marrow cell-treated mice. Markees TG; De Fazio SR; Gozzo JJ Transplantation; 1990 Dec; 50(6):911-4. PubMed ID: 2256160 [TBL] [Abstract][Full Text] [Related]
2. Prolonged adult skin allograft survival as a result of cotransplantation with neonatal tissue. The requirement for antigen sharing between graft and cotransplant. Markees TG; De Fazio SR; Gozzo JJ Transplantation; 1992 Dec; 54(6):955-8. PubMed ID: 1465789 [TBL] [Abstract][Full Text] [Related]
3. Tolerogenic behavior of skin allografts from neonatal mice. Markees TG; De Fazio SR; Gozzo JJ Transplantation; 1994 Nov; 58(9):1008-14. PubMed ID: 7974727 [TBL] [Abstract][Full Text] [Related]
4. Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice. Ohzato H; Monaco AP Transplantation; 1992 Dec; 54(6):1090-5. PubMed ID: 1465774 [TBL] [Abstract][Full Text] [Related]
5. Induction of allograft tolerance with neonatal skin. Jamshidi F; De Fazio SR; Markees TG; Gozzo JJ Transplantation; 1991 May; 51(5):1048-52. PubMed ID: 2031261 [TBL] [Abstract][Full Text] [Related]
6. Allograft and xenograft unresponsiveness induced by transplantation of neonatal skin. Jamshidi F; De Fazio SR; Gozzo JJ Transplantation; 1993 Jul; 56(1):135-8. PubMed ID: 8333035 [TBL] [Abstract][Full Text] [Related]
7. Indefinite survival of skin allografts in adult thymectomized, antilymphocyte serum-treated mice given bone marrow and thymus grafts of donor origin: tolerance induction by donor bone marrow and thymus. Fukuzaki T; Hancock WW; Monaco AP; Maki T Transplantation; 1998 Apr; 65(8):1036-43. PubMed ID: 9583862 [TBL] [Abstract][Full Text] [Related]
8. Late adjunctive therapy with single doses of rapamycin in skin-allografted mice treated with antilymphocyte serum and donor bone marrow cells. De Fazio SR; Plowey JM; Hartner WC; Gozzo JJ Transpl Immunol; 1996 Jun; 4(2):105-12. PubMed ID: 8843586 [TBL] [Abstract][Full Text] [Related]
9. An essential role for natural killer cells in augmentation of allograft survival mediated by donor spleen cells. Goldstein DR; Thomas JM; Kirklin JK; George JF Transplantation; 2001 Sep; 72(5):954-6. PubMed ID: 11571465 [TBL] [Abstract][Full Text] [Related]
10. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow. Hale DA; Gottschalk R; Maki T; Monaco AP Transplantation; 1998 Feb; 65(4):473-9. PubMed ID: 9500619 [TBL] [Abstract][Full Text] [Related]
11. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin. Dono K; Maki T; Wood ML; Monaco AP Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521 [TBL] [Abstract][Full Text] [Related]
12. Association between epidermal interleukin-10 secretion and the ability of cotransplanted skin from neonatal donors to prolong adult allograft survival. Markees TG; Jamshidi F; De Fazio SR; Gozzo JJ Transplantation; 1996 Jan; 61(1):111-5. PubMed ID: 8560548 [TBL] [Abstract][Full Text] [Related]
13. Prolongation of impure murine islet allografts with antilymphocyte serum and donor-specific bone marrow. Markees TG; De Fazio SR; Gozzo JJ Transplantation; 1992 Mar; 53(3):521-7. PubMed ID: 1549842 [TBL] [Abstract][Full Text] [Related]
14. Effect of posttransplantation administration of peripheral blood lymphocytes in skin-grafted mice treated with antilymphocyte serum or antilymphocyte serum plus bone marrow. De Fazio SR; Hartner WC; Monaco AP; Gozzo JJ Transplantation; 1987 Jul; 44(1):70-5. PubMed ID: 3299924 [TBL] [Abstract][Full Text] [Related]
15. Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow. Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP Transplantation; 1997 Feb; 63(3):359-64. PubMed ID: 9039923 [TBL] [Abstract][Full Text] [Related]
16. A differential requirement for CD8+ donor cells in the augmentation of allograft survival by posttransplantation administration of donor spleen cells and donor bone marrow cells. Goldstein DR; Chang T; Sweeney SD; Kirklin JK; Thomas JM; George JF Transplantation; 2000 Oct; 70(7):1068-73. PubMed ID: 11045644 [TBL] [Abstract][Full Text] [Related]
17. The effect of timing of skin grafts on subsequent survival in ALS-treated, marrow-infused mice. Wood ML; Monaco AP Transplantation; 1977 Jan; 23(1):78-86. PubMed ID: 65036 [TBL] [Abstract][Full Text] [Related]
18. Requirement for early donor cell chimerism during prolonged survival of murine skin allografts. Masli S; De Fazio SR; Gozzo JJ Transplantation; 2000 Apr; 69(8):1667-75. PubMed ID: 10836379 [TBL] [Abstract][Full Text] [Related]
19. Suppressor cells in specific unresponsiveness to skin allografts in ALS-treated, marrow-injected mice. Wood ML; Monaco AP Transplantation; 1980 Mar; 29(3):196-200. PubMed ID: 6444769 [TBL] [Abstract][Full Text] [Related]
20. Skin allograft survival following intrathymic injection of donor bone marrow. Cober SR; Randolph MA; Lee WP J Surg Res; 1999 Aug; 85(2):204-8. PubMed ID: 10423320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]